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BY KEITH H. BRIDWELL, MD, PAUL A. ANDERSON, MD, 
SCOTT D. BODEN, MD, ALEXANDER R. VACCARO, MD, AND JEFFREY C. WANG, MD
What’s New in the Treatment 
of the Cervical Spine
An increasing number of prospective studies have established 
the efficacy of many cervical spine procedures. At the same 
time, complications and morbidity have been critically ana-
lyzed. Several of these studies regarding anterior fusion and 
laminoplasty will be reviewed.
Outcomes
Long-term follow-up with use of validated instruments and 
strict radiographic criteria are effective for evaluating surgical 
results. The Cervical Spine Research Society prospectively fol-
lowed 181 patients for two years to assess the influence of 
plates on outcomes. In patients with single-level fusions, the 
use of a plate was associated with a significantly higher rate of 
successful fusion (94% compared with 73%). Rigid and trans-
lational plates were associated with better results than plates 
that only allowed the toggle of screw heads. Other studies of 
intervertebral fusion devices have demonstrated conflicting 
results. Carbon fiber-reinforced spacers used as stand-alone 
devices had results similar to allografts, whereas tantalum 
mesh implants had poor results that necessitated the discon-
tinuation of a randomized study.
Pulsed electromagnetic field stimulation has been 
shown to induce fusion in the lumbar spine and the healing of 
extremity nonunions. In a prospective, randomized study, 
pulsed electromagnetic field stimulation was associated with 
higher rates of successful cervical fusion (84% compared with 
69%), although no significant differences in functional out-
comes were noted. Interestingly, successful fusion, either with 
or without pulsed electromagnetic field stimulation, was sig-
nificantly correlated with good clinical outcomes. Controver-
sies still remain with regard to the approach (i.e., anterior or 
posterior) for treatment of cervical spondylotic myelopathy. 
In a randomized study comparing corpectomy and autograft 
fusion with laminoplasty, no differences were noted with re-
gard to the rate of neurologic recovery or the range of motion 
of the neck. However, both groups had significant improve-
ment in neurologic function. Axial pain was greater in the 
laminoplasty group. Complications in the anterior treatment 
group included dysphagia and pseudarthrosis, whereas those 
in the laminoplasty group included motor root paralysis and 
increased kyphotic angulation.
Recombinant human bone morphogenetic protein-2 
(rhBMP-2) has been used off-label to promote fusion follow-
ing anterior cervical discectomy, with fusion rates of 100% 
having been noted. A recent warning letter from the manufac-
turer was sent to surgeons, noting that some patients have had 
development of hematoma and postoperative retropharyn-
geal swelling with symptoms of dysphagia, hoarseness, and 
airway obstruction requiring reintubation. The exact etiology 
is unclear but most likely is related to an inflammatory effect 
resulting from a high protein dose. The use of fibrin glue to 
control the spread of BMP may limit its dispersion and has 
been shown to have a protective effect on the neuroelements 
from undesired bone formation. Its use for the prevention of 
the retropharyngeal inflammatory response observed in asso-
ciation with cervical off-label use has not been examined.
Laminoplasty
Laminoplasty has gained in popularity for the treatment of 
cervical myelopathy secondary to ossification of the posterior 
longitudinal ligament and spondylosis with spinal stenosis. 
The major morbidities include C5 motor-root paralysis (in 
5% to 10% of patients) and chronic neck pain (in up to 30% 
of patients). Many etiologies for C5 motor paralysis have been 
hypothesized, including the suggestion that the C5 root is 
short, is tethered, and branches at a right angle at the apex of 
the lordosis and therefore is subjected to greater traction when 
the spinal cord shifts posteriorly. Another etiology, newly 
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identified, is cord rotation. Increasing rotation of the cord in 
excess of 4° has been significantly associated with postopera-
tive C5 paralysis in comparison with other factors such as the 
compression ratio or the presence of foraminal stenosis.
During laminoplasty, continuous electromyographic 
monitoring of the C5 root can identify a deficit early. Posi-
tive findings are spontaneous discharges, which can lead 
to changes in the procedure such as adjustments of arm 
positioning or alterations in decompressive techniques. 
Another method is prophylactic bilateral C4-C5 foraminal 
decompression.
Several techniques to reduce axial neck complaints 
following laminoplasty have been proposed. These proposed 
techniques have included preservation of the C7 spinous pro-
cess, maintenance of the insertion of the semispinalis cervicus 
insertion into C2, and elimination of bracing and initiation of 
early range of motion, especially extension.
Morbidity
The anterior cervical approach is occasionally associated with 
long-term voice disturbances and dysphagia. In the Cervical 
Spine Research Society outcome study, the incidence of new-
onset dysphagia after surgery was 29.8% at three months, 
6.9% at six months, and 6.6% at two years. The use of plates 
resulted in a 1.6-times higher incidence, and higher rates were 
noted following procedures involving multiple levels and 
more cephalic levels.
Newer translational plates allow settling in the long axis 
of the spine after interbody graft resorption and theoretically 
result in higher fusion rates. Most plate designs use oblong 
holes, and, as settling occurs, the plate translates toward the 
next adjacent nonfused level. Plates within 5 mm of nonfused 
disc spaces have been associated with adjacent-level disc ossifi-
cation. This phenomenon, when occurring within three 
months after surgery, is likely to be progressive.
Esophageal perforations occur rarely in anterior spine 
surgery but can be devastating. If concern arises, the integrity 
of the esophagus may be tested by esophageal injection of con-
trast media such as methylene blue. Placement of a Foley cath-
eter cephalad and caudad to the suspected lesion allows 
increased pressurization and substantially increases the sensi-
tivity of this test.
What’s New in Biologic 
Topics Related to the Spine
Biologic tools for reconstruction and regeneration continue to 
be one of the most researched areas related to the spine today. 
There is a continued effort to enhance the process of achieving 
spine fusion. With the United States Food and Drug Adminis-
tration’s postmarketing approval of rhBMP-2 in 2002 and its 
Humanitarian Device Exemption for rhBMP-7 late in 2004, 
the era of using recombinant bone morphogenetic proteins to 
achieve spine fusion is here. In fact, some would argue that the 
limited number of available bone-growth factors has resulted 
in increased efforts to promote motion-sparing technologies. 
There continues to be increased activity related to the devel-
opment of lower-cost bone-graft substitutes as well. Finally, an 
increasing amount of research continues to be focused on un-
derstanding the biology of the intervertebral disc and develop-
ing biologic strategies to retard or reverse degeneration.
Recombinant Osteoinductive Proteins
Since the Food and Drug Administration granted postmarket-
ing approval for the use of rhBMP-2 inside an anterior spine 
fusion cage, rhBMP-2 on an absorbable collagen sponge car-
rier has been used by surgeons in closely related applications. 
In the last year, very high rates of successful fusion (>95%) 
have been reported when rhBMP-2 has been used for trans-
foraminal lumbar interbody fusion in conjunction with a poly 
(L-lactide-co-D,L-lactide) bioresorbable spacer or a nonre-
sorbable cage. In addition, rhBMP-2 was associated with a 
fusion rate of 100% in a study of twenty patients who were 
managed with anterior cervical interbody fusion in conjunc-
tion with a bioresorbable spacer.
There have been sporadic reports of transient post-
operative edema and/or swelling in the anterior cervical area, 
which may be associated with rhBMP-2 when used in high 
doses. Since use in the anterior cervical spine is not a currently 
approved marketing label for rhBMP-2, extensive safety data 
related to this use are not available and therefore surgeons are 
reminded to exercise caution and to be aware of the potential 
perioperative risks. A second complication resulting from 
BMP was reported in association with the use of stand-alone 
titanium fusion cages for posterior lumbar interbody fusion. 
A two-year multicenter pilot study demonstrated that several 
patients had posterior overgrowth of bone into the spinal 
canal, most likely because of inadequate countersinking of 
the metal cage. The patients with bone overgrowth did not 
report worse clinical outcomes, and the rate of successful fu-
sion was 93%.
One-year results were reported following the use of 
rhBMP-7 as a replacement for iliac crest autograft in patients 
managed with posterolateral lumbar arthrodesis for the treat-
ment of degenerative spondylolisthesis. That prospective, 
randomized, controlled, multicenter clinical study involved 
radiographic follow-up of twenty-nine of thirty-five patients 
and demonstrated a 74% rate of successful fusion in the BMP-
7 group as determined on the basis of plain radiographs. The 
fusion rate in the autograft control group was similar (60%). 
There was no significant difference between the rhBMP-7 group 
and the autograft group with regard to clinical outcomes as de-
termined with Oswestry and SF-36 pain index scores.
The United States Food and Drug Administration 
granted a Humanitarian Device Exemption authorizing the 
use of rhBMP-7 for the treatment of established posterolateral 
spine pseudarthrosis when the use of bone marrow or iliac 
crest bone is not possible. The Humanitarian Device Exemp-
tion approval establishes the safety of a device but clearly states 
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that its effectiveness has not been demonstrated. This is a rela-
tively new approval mechanism that surgeons should be sure 
that they understand. The Humanitarian Device Exemption 
approval process requires the hospital institutional review 
board to approve the use of the device for the specific indica-
tion authorized by the Humanitarian Device Exemption. 
Since the institutional review board protocol specifies the use 
authorized by the Humanitarian Device Exemption, off-label 
use is not permitted by the institutional review board as it 
would be a violation of the protocol. The Humanitarian De-
vice Exemption device still must be treated as an experimental 
device from the standpoint of the institutional review board. 
Surgeons and appropriate hospital committees should famil-
iarize themselves with these rules in detail. Although there are 
no published data on the use of rhBMP-7 for the treatment of 
posterolateral pseudarthrosis in humans, a study on the treat-
ment of nonunions in rabbits demonstrated that the rate of 
successful fusion associated with rhBMP-7 (82%) was supe-
rior to that associated with autograft (42%). The dose was 
identical to that recommended for human use and is some-
what lower than doses typically required for consistent bone 
induction by other BMPs in primates. In another study, which 
involved three-level posterolateral uninstrumented fusion in a 
sheep model, rhBMP-7 demonstrated no improvement with 
regard to healing compared with autograft. That mechani-
cally challenging model emphasized the point that even po-
tent osteoinductive proteins cannot independently overcome 
an unstable mechanical environment.
A third osteogenic protein, known as Growth and Dif-
ferentiation Factor-5 (GDF-5), is also being tested for spine 
fusion applications. This protein recently was reported to 
generate successful endoscopic posterolateral spine fusions 
in sheep and currently is under investigation in human clini-
cal trials.
Other Bone-Graft Substitutes
Given the relatively high cost of recombinant BMPs, a variety 
of other bone-promoting strategies continue to be investi-
gated. Demineralized bone matrix (DBM), which contains 
natural BMPs (if properly processed), continues to be used in 
clinical practice. A common misconception is that all DBMs 
are the same. In a recent study from the University of Califor-
nia at Los Angeles, a rat spine fusion model was used to dem-
onstrate a stark difference between three brands, ranging from 
no activity (Allomatrix), to inconsistent activity (DBX), to 
consistent fusion (Grafton). As the study involved immune-
deficient rats, human bone taken from product inventory in 
an operating room was used. Since last year, two additional 
published studies (one human study and one pig study) have 
failed to show any enhancement of bone-healing in associa-
tion with the use of platelet gel concentrates.
Biologic Treatments for Disc Degeneration
Disc degeneration remains an endemic reality of aging. As is 
the case with most conditions, there is likely to be some ge-
netic predisposition. A study from Finland added support 
to earlier studies linking vitamin D polymorphisms to disc dis-
ease and proposed a possible association between interleukin-1 
gene polymorphisms and low-back pain. That study was 
unique in that it correlated the genetic findings with a clinical 
symptom rather than a radiographic observation. Another 
study demonstrated smoking-induced chondrocyte meta-
bolic changes, including increased levels of interleukin-1 beta, 
in a rat model.
There has been continued interest in studying the effects 
of BMPs on disc chondrocyte function. Studies from Atlanta 
have demonstrated similar results with BMP-2 increasing ag-
grecan, collagen type II, TGF-beta, and BMP-7 mRNA just as 
have been reported for some time with BMP-7 and TGF-beta. 
As further evidence of the attention that this field is receiving, 
the 2004 International Society for the Study of the Lumbar 
Spine prize was awarded to a paper demonstrating the ability 
of the intracellular regulatory protein, LMP-1, to upregulate 
intervertebral disc cell production of proteoglycans and multi-
ple BMPs in vitro and in vivo. Thus, several groups have dem-
onstrated some short-term responses to BMPs and now LMP 
in the intervertebral disc, but the key issues are whether or not 
any of these strategies can work in primates, whether they can 
retard or reverse disc degeneration, and what the duration of 
any beneficial effect may be.
What’s New in Spinal Deformity Surgery
The definition and scope of spinal deformity continues to 
evolve. Certainly, the term spinal deformity includes condi-
tions such as idiopathic adolescent scoliosis, congenital scolio-
sis, posttraumatic deformities, and adult spinal deformities. 
Motion preservation and spondylolisthesis are considered by 
the Scoliosis Research Society to be within the realm of spinal 
deformity.
Genetics
Work continues to evolve on the genetic etiology of idio-
pathic scoliosis. It appears that the pathogenesis of idio-
pathic scoliosis is complex and is affected by both genetic 
and environmental factors. There are also data from Den-
mark suggesting that there is a substantial genetic compo-
nent to Scheuermann kyphosis.
Etiology and Natural History of Idiopathic Scoliosis
We still have a long way to go in understanding the etiology of 
idiopathic scoliosis. Cheung reported that pinealectomy did 
not result in the development of scoliosis in young nonhuman 
primates. That study calls into question whether or not mela-
tonin is a factor in primates. Work from Montreal, however, 
suggests that melatonin signal transduction is impaired in pa-
tients with severe idiopathic scoliosis. This theory was based 
on primary cell cultures prepared from musculoskeletal tis-
sues from these patients.
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Surgical Treatment of 
Adolescent Idiopathic Scoliosis
There is still considerable debate about the treatment of 
thoracic curves. Options include both anterior and posterior 
treatment and, for larger curves, anterior release. To some 
extent, the use of thoracic pedicle screws is changing the tide-
mark. In many instances, it now appears that anterior release 
is not necessary if pedicle screw fixation can be utilized. There 
is still considerable debate about the advantages of using a 
construct of apical sublaminar wires as opposed to pedicle 
screws. Both techniques work well. Perhaps of bigger concern 
is the prevalence of either proximal or distal junctional kypho-
sis after treatment. The prevalence of junctional kyphosis may 
be somewhat higher in association with the use of pedicle 
screws. It certainly appears that the prevalence of junctional 
kyphosis is greater in association with the use of a posterior 
approach than it is in association with the use of an anterior 
approach. It appears that anterior treatment provides a more 
reliable correction of the hypokyphotic thoracic spine than 
posterior instrumentation does. On balance, it appears that 
there is still a role for anterior and posterior treatment as well 
as for hooks, apical sublaminar wires, and pedicle screws. One 
particular technique is not clearly superior to another.
Adult Spinal Deformity
The surgical treatment of adult spinal deformity remains one 
of the biggest challenges in spinal deformity surgery. There is 
a role for Smith-Petersen osteotomy, pedicle subtraction pro-
cedures, and posterior vertebral column resection for the 
treatment of sagittal and coronal fixed imbalance. With long 
fusions to the sacrum, protection of the sacral screws by 
means of both anterior column support and pelvic fixation 
(iliac screws) has many advantages but does not completely 
eliminate the risk of pseudarthrosis. It is possible to harvest 
iliac bone if the surgeon stays at least 1 cm away from the iliac 
screws without running the risk of loosening these screws. A 
clinical outcomes assessment of patients with adult scoliosis 
indicated that a markedly positive sagittal balance is the most 
disabling component of adult spinal deformity. Of the various 
adult scoliosis curve patterns, those with lower curve apices 
and diminished lumbar lordosis are the most problematic, 
irrespective of the coronal curve magnitude.
Congenital Scoliosis
Progress in the recognition, evaluation, and treatment of 
thoracic insufficiency syndrome continues. Thoracic insuf-
ficiency syndrome is a rare condition that represents the 
pathologic situation in which postnatal lung tissue growth 
is inhibited by chest cavities with suboptimal volumetric 
characteristics. The treatment of this condition focuses on 
the chest wall deformity as opposed to the spinal deformity. 
Chest wall expansion with use of the VEPTR (Vertical Ex-
pandable Prosthetic Titanium Rib) procedure has been ad-
vanced as a method of altering the natural history of thoracic 
insufficiency syndrome. This procedure is utilized for small 
children and requires lengthening of the device at six-month 
intervals. The complication rates are high and are in keeping 
with those encountered in patients undergoing growing 
spinal rod procedures. One study that was presented at the 
annual Scoliosis Research Society meeting in Argentina dem-
onstrated 455 adverse events in 154 patients. Seventy-five per-
cent of those events were judged to be moderate or minor, 
whereas 21% were viewed as serious. Currently, there are no 
long-term data to support this approach of chest wall expan-
sion as a treatment for thoracic insufficiency syndrome, but 
study is ongoing.
Surgical Complications
Iatrogenic spinal fracture through vertebrae that have been 
treated with pedicle screws has recently been recognized. This 
lesion occurs at the end vertebra and is characterized as a 
three-column fracture-dislocation. It is most commonly seen 
at the cephalad end of a thoracic construct in osteoporotic pa-
tients. Vertebral translation can occur, and spinal cord injury 
has been reported. The key to treatment is early recognition, 
prior to the development of substantial deformity or neuro-
logic sequelae. Surgical salvage is required but is not always 
satisfactory.
The impact of having vertebral body screws in close 
proximity to the aorta is still not clear. There is still quite a bit 
of concern about this, although clinically the number of either 
acute or delayed aortic perforations by anterior vertebral body 
screws appears to be extremely low.
Spinal Biomechanics
On the basis of the work by Roussouly et al., we now know 
that the C7 plumb line and the center-of-gravity line are 
not identical. We know that sagittal imbalance is quite dis-
abling; however, we still struggle somewhat with deciding 
what degree of surgical correction will produce “ideal bal-
ance.” We need to learn more about the center of gravity 
and also about the compensatory mechanisms that occur 
belw the spine (e.g., hip extension, knee flexion, and 
ankle dorsiflexion) to understand factors that determine 
sagittal balance and to understand the potential remedies 
for imbalance.
Motion Preservation
The Scoliosis Research Society remains quite interested in mo-
tion preservation and the use of disc arthroplasty. One of the 
lumbar disc arthroplasty devices has now been approved by 
the Food and Drug Administration. Acceptable results have 
been reported after two to five years of follow-up. Concerns 
still exist about the long-term durability of the devices as well 
as about the options for revision, especially at L4-L5. At this 
level, any interbody device will be in close proximity to the 
iliac veins, and, therefore, revision has the potential for cata-
strophic complications. Range of motion does seem to be pre-
1896
 TH E JO U R NA L OF BONE & JOINT SURGER Y ·  JBJS .ORG
VO LU M E 87-A ·  NUMB ER 8 ·  AU G U S T 2005
WH A T’S NE W I N SP I N E SURGER Y
What’s New in Spine Surgery
served following disc arthroplasty, and the prevalence of 
heterotopic ossification is low.
Spondylolisthesis
There continues to be a trend toward reduction and circum-
ferential fusion rather than fusion in situ for the treatment of 
high-grade dysplastic spondylolisthesis. However, reduction is 
associated with a higher prevalence of L5 root deficits. These 
deficits usually resolve with time. Efforts are being made to 
understand the factors that differentiate between nonprogres-
sive lytic nondysplastic spondylolisthesis and lytic highly dys-
plastic progressive high-grade spondylolisthesis. These factors 
include dysplasia of the posterior elements and changes in the 
sacral dome and the growth plate of the proximal part of the 
sacrum. Pelvic incidence (the sum of sacral slope and pelvic 
tilt) also may be a factor in the development and progression 
of spondylolisthesis.
What’s New in Spinal Cord Injury
The tragic death of Christopher Reeve in 2004 brought to the 
forefront of public attention the ongoing challenges faced by 
individuals suffering from paralysis due to spinal cord inju-
ries and served as a harsh reminder of the desperate need for 
therapies for this devastating injury. Experimental therapies 
designed to provide neuroprotection and possibly also axonal 
regeneration, which were once almost the exclusive domain of 
basic science researchers, are now emerging from the bench as 
potential candidates for clinical trials focusing on the treat-
ment of spinal cord injury in humans.
Pharmacologic Agents
Recent reports from the neurobiology community have dem-
onstrated encouraging progress in the study of pharmaco-
logic agents that appear to have substantial neuroprotective 
properties but are also already in clinical use for other, unre-
lated applications. This obviously has important implications 
for surgeons because the long-established safety and tolerance 
of such drugs in humans certainly would facilitate their entry 
into clinical trials on the treatment of spinal cord injury. The 
drugs that have generated such interest include erythropoi-
etin, minocycline, and atorvastatin. Independent laboratories 
have reported that erythropoietin has demonstrated beneficial 
effects in animal models of acute spinal cord injury, and a 
great deal has been learned recently about the unique mecha-
nisms, unrelated to its hemopoietic effects, by which this 
erythropoietic hormone confers tissue protection. Four inde-
pendent laboratories have demonstrated the neuroprotective 
effects of minocycline (including tissue protection, dimin-
ished cell death, and improved functional outcome) in animal 
models of acute spinal cord injury. The neuroprotective effects 
of minocycline were first reported in cerebral injury models 
and recently were introduced into human clinical studies on 
the basis of the encouraging results noted in animal models of 
spinal cord injury. Atorvastatin (more commonly known as 
Lipitor) and the other statins that are in use as cholesterol-
lowering agents also have been found to have important 
anti-inflammatory properties and thus have been applied in 
various animal models of stroke, Alzheimer disease, and, most 
recently, spinal cord injury. A recent animal study demon-
strated that atorvastatin reduced tissue damage at and around 
the site of spinal cord injury and also promoted motor recov-
ery. Unfortunately, in that study, the atorvastatin was given 
one week before the injury, and additional results with this 
drug in a more clinically applicable model are anxiously 
awaited. In any event, the promising results of these preclinical 
animal studies and the long-established human safety of these 
drugs have prompted great interest in initiating clinical trials.
Cellular Transplantation
In the case of orthopaedic surgeons, an interest in cellular 
transplantation strategies that might promote functional re-
covery after spinal cord injury is only natural, for the very 
practical reason that our involvement might be necessary 
for their application. The experience with cell transplanta-
tion for the treatment of acute and chronic spinal cord in-
jury is increasing around the world, and, in an attempt to 
provide an international forum for the open discussion of 
these therapies, the International Campaign for the Cure of 
Paralysis hosted the Clinical Trials workshop in Vancouver, 
British Columbia, in February 2004. Scientists and clini-
cians from around the world discussed their experience with 
human transplantation treatments with olfactory ensheath-
ing cells, peripheral nerve grafts, and autologous activated 
macrophages. Much excitement around the use of olfactory 
ensheathing cells has led investigators in Lisbon, Portugal; 
Beijing, China; and Brisbane, Australia to initiate transplan-
tation trials in humans.
In cord transection studies in animals, Schwann cells 
derived from bone marrow stromal cells transplanted to the 
injury zone resulted in substantially greater distal motor re-
covery. Similarly, olfactory ensheathing cells, which have a 
unique capacity of growing from the central nervous system 
to the peripheral nervous system, also have been shown to 
promote recovery.
Granulocyte macrophage-colony stimulating factor 
(GM-CSF) is a hematopoietic cytokine that activates stem 
cells and prevents apoptosis of leukocytes. Similar apoptotic 
pathways occur in both neuronal and hematopoietic systems. 
Therefore, GM-CSF may have an effect in spinal cord injuries. 
In a rat model, GM-CSF was found to be neuroprotective and 
to prevent neuronal apoptosis. In another study, transplanta-
tion of bone marrow cells stimulated by GM-CSF was shown 
to improve neurologic recovery in animals.
It is important for us as surgeons to have some aware-
ness that these trials are ongoing because one can be quite as-
sured that our patients, with their access to the Internet, are 
becoming increasingly informed about them. At this moment, 
peer-reviewed reporting of these trials is unavailable.
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Use of Methylprednisolone
While the current evaluation of these novel technologies is 
generating much excitement and hope within the spinal cord 
injury field, the ongoing debate regarding the acute adminis-
tration of methylprednisolone is closer to the front-line phy-
sician who is treating spinal cord injuries. After the initial 
criticisms directed at the methodology and interpretation of 
the National Acute Spinal Cord Injury Study (NASCIS) 2 and 
3 trials, critical reviews of the use of methylprednisolone have 
been conducted by the American Association of Neurologic 
Surgeons, the Congress of Neurologic Surgeons, the Cana-
dian Spine Society, and the Canadian Neurologic Society. All 
have come to the conclusion that methylprednisolone should 
not be considered a part of the clinical or medicolegal stan-
dard of care for patients with acute spinal cord injuries, but 
rather that it should be a treatment option only. An interesting 
study from the Miami Project, which highlighted the potential 
hazards of methylprednisolone, was published in 2004. The 
authors performed muscle biopsies during spinal stabilization 
and subsequent electromyography on five acutely injured pa-
tients who received the NASCIS 2 methylprednisolone regime 
and three patients who did not. Four of the five patients who 
received methylprednisolone had evidence of acute steroid 
myopathy and also had corresponding functional changes on 
electromyography. All three patients who did not receive ste-
roids had normal findings on muscle biopsy and on elec-
tromyography.
Clearly, the spinal cord injury field has entered an excit-
ing time in which new therapies directed at the treatment of 
neurologic injury are entering into clinical trials.
What’s New in the 
Treatment of the Lumbar Spine
Degenerative disorders of the lumbar spine continue to be 
some of the most common clinical problems that patients face 
today, and they account for a large percentage of time lost 
from work in the general population. Accordingly, novel ap-
proaches for the treatment of these degenerative conditions 
continue to represent some of the most impressive technologi-
cal advances seen in any medical field. The quest for new tech-
nology and improvements of commonly accepted treatments 
are among the most exciting areas of spinal surgery.
Lumbar Disc Arthroplasty
The use of total disc arthroplasty as a motion-preserving pro-
cedure continues to be a potentially exciting treatment for 
lumbar spine disorders. Blumenthal et al., in a two-year 
follow-up study of 304 patients from fifteen centers who had 
been enrolled in a Food and Drug Administration trial in 
which fusion was compared with lumbar disc arthroplasty 
for the treatment of single-level lumbar disease, reported 
greater improvement in visual analog scale pain scores for 
the arthroplasty group at all follow-up times except for 
twenty-four months.
Zigler et al., in a twelve to twenty-four-month follow-up 
study in which circumferential fusion was compared with disc 
arthroplasty performed with use of a different implant, re-
ported that the patients managed with disc arthroplasty had a 
shorter operative time, less blood loss, and a shorter hospital 
stay. Clinical outcomes were comparable between the two 
groups, with the arthroplasty group demonstrating superior 
outcomes at some of the follow-up time-points.
The relationship between motion after disc arthroplasty 
and clinical outcome was examined by a group of investigators 
from The Hospital for Special Surgery. Huang et al., in a study 
of thirty-eight patients from European centers who were as-
sessed at a mean of 8.6 years after lumbar disc arthroplasty at 
one or two levels, reported significant associations between 
the range of motion of the segments and an improved clinical 
outcome. However, the long-term results of disc arthroplasty 
need to be compared with those of fusion.
Biological Promoters of Fusion
BMP-2 is known to induce spinal fusion in certain spinal ap-
plications. The use of BMP-2 with allograft bone for anterior 
spinal fusion was examined to evaluate the amount of incor-
poration of the allograft bone. Burkus et al., in a multicenter 
study of 131 patients who underwent interbody fusion with 
use of allograft dowels combined with either BMP-2 (seventy-
nine patients) or autogenous bone graft (fifty-two patients), 
reported increased bone formation and higher percentages of 
complete allograft incorporation in the BMP-2 group. How-
ever, there is a concern that the use of BMP-2 with allograft 
materials may allow for aggressive allograft resorption, result-
ing in undesired weakening of the graft and the potential for 
adverse effects on the structural integrity of the graft and, ulti-
mately, for the spinal fusion. This issue certainly will need to 
be better defined with future studies.
The issue of cost associated with the use of spinal im-
plants and graft substitutes was examined in a study by re-
searchers in Durango, Colorado, in which iliac crest bone 
graft was compared with allograft composite with bone mar-
row concentrate. Specifically, Youssef et al. assessed the hos-
pital costs associated with the harvesting of autogenous iliac 
crest bone graft as well as the decreased time needed when 
using the graft composite and found that the overall effect 
was cost-neutral. This is an important factor to consider 
when evaluating novel bone-graft substitutes and determin-
ing whether the benefits of these substitutes can be measured 
in terms of cost-savings in addition to the potential benefits 
that they provide to patients by obviating the need for autog-
enous bone-grafting.
Surgical Complications
The prevention of surgical complications is always an impor-
tant issue, and identifying risk factors for these problems is 
a top priority. Nepple et al., in a study based on a cohort of 
2245 patients from one major medical center, reported that 
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diabetes, the use of two resident surgeons, the use of red 
blood-cell transfusions, and obesity were all independent 
risk factors for surgical wound infections following spinal 
surgery.
Ahn et al., in a presentation based on a series of 1867 
patients who had been enrolled in a multicenter study evalu-
ating predisposing factors for intraoperative dural tears, re-
ported that dural tears during surgery were significantly more 
common in patients who smoked, had diabetes, or had had 
an excessive number of epidural steroid injections (more than 
three during the six months before surgery). Patients who had 
a combination of these risk factors exhibited a markedly in-
creased risk of intraoperative dural tears, indicating that sur-
geons should exhibit caution when treating these patients in 
particular.
Although resorbable implants remain a novel and po-
tentially exciting concept, Herceg et al. noted rapid subsidence 
in their report on thirty-five lumbar levels that had been 
treated with circumferential fusion with use of a resorbable 
anterior ring device combined with BMP-2 and posterior 
pedicle screws. At six months, 40% of the devices had sub-
sided ≤6 mm, 40% had subsided 7 to 9 mm, and 20% had 
subsided >10 mm. The fusion rate was 88%, and clinical out-
comes were good; however, the rapid subsidence led to subse-
quent surgery in two patients and to collapse and alterations 
in pedicle screw alignment in several others.
Jenis et al. reported on the complication of symptom-
atic radiculopathy due to malpositioned pedicle screws. In 
their report on 838 patients, twenty-one had postoperative 
radiculopathy due to malpositioned screws. The overall 
prevalence of this complication was 0.48%; however, no 
correlation was identified between the clinical outcome 
and the use of conservative treatment prior to removal, the 
involved nerve level, or the duration until onset of symp-
toms. Substantial improvement was noted when screw re-
moval was performed less than sixty days after the onset 
of symptoms; however, there was greater improvement when 
removal was performed less than fourteen days after the on-
set of symptoms. The patients with the most recovery were 
those who had screw removal less than twenty-one days after 
the index procedure, regardless of the time of onset of the 
symptoms.
Patient Satisfaction
When treating patients, surgeons desire good outcomes with 
high rates of patient satisfaction. Carragee et al., in a prospec-
tive study of 168 consecutive patients undergoing lumbar de-
compression surgery, reported that patient expectations and 
satisfaction were complex variables. Patients with spinal 
stenosis expected less from surgery and were satisfied when 
these lower expectations were met. However, patients with 
herniated discs expected very good outcomes with regard to 
function and pain and were dissatisfied if these expectations 
were not achieved.
Evidence-Based Orthopaedics
The editorial staff of The Journal reviewed a large number of 
recently published research studies related to the musculoskel-
etal system that received a Level of Evidence grade of I. Over 
100 medical journals were reviewed to identify these articles, 
which all have high-quality study design. In addition to arti-
cles published previously in this journal or cited already in this 
update, seventeen level-I articles were identified that are rele-
vant to spine surgery. A list of those titles is appended to this 
review after the standard bibliography. We have provided a 
brief commentary about each of the articles to help guide your 
further reading, in an evidence-based fashion, in this subspe-
cialty area.
Upcoming Meetings and Events 
Related to Spine Surgery
The twentieth annual meeting of the North American Spine 
Society (NASS) will be held on September 27 through October 
1, 2005, at the Pennsylvania Convention Center in Philadel-
phia, Pennsylvania. Web site: www.spine.org.
The fortieth annual meeting of the Scoliosis Research 
Society (SRS) will be held on October 27 through 30, 2005, at 
the Loews Miami Beach Hotel in Miami, Florida. It will be 
preceded by two one-day courses on Adult Spinal Deformity 
and The Immature Spine, to be held on October 26, 2005. 
Web site: www.srs.org.
The thirty-third annual meeting of the Cervical Spine 
Research Society (CSRS) will be held on December 1 through 
3, 2005, at the Manchester Grand Hyatt in San Diego, Califor-
nia. The twenty-second annual meeting of the CSRS European 
Section will be held on May 17 through 20, 2006, in Berlin, 
Germany. Web site: www.csrs.org.
The Federation of Spine Associations will present the 
spine program at Specialty Day at the Annual Meeting of 
the American Academy of Orthopaedic Surgeons, to be held 
on March 11, 2006, in New Orleans, Louisiana. Web site: 
www.aaos.org.
The annual meeting of the International Society for the 
Study of the Lumbar Spine (ISSLS) will be held on June 13 
through 17, 2006, in Bergen, Norway. Web site: www.issls.org.
The thirteenth annual International Meeting on Advanced 
Spine Techniques (IMAST) will be held on July 12 through 16, 
2006, in Athens, Greece. Web site: www.imastonline.com.
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Evidence-Based Articles Related to Spine Surgery
Assendelft WJ, Morton SC, Yu EI, Suttorp MJ, Shekelle PG. Spinal manipula-
tive therapy for low back pain. Cochrane Database Syst Rev. 2004;1:CD000447.
This study was a meta-analysis of fifty-three articles on thirty-nine 
randomized, controlled trials evaluating the effectiveness of spinal manipula-
tive therapy for the treatment of low-back pain. The conclusion of the study 
was that there is no evidence that spinal manipulative therapy is superior to 
other standard treatments (physical therapy, analgesics, exercises, back school, 
or general practitioner care) for patients with acute or chronic low-back pain.
Brown EM, Pople IK, de Louvois J, Hedges A, Bayston R, Eisenstein SM, Lees 
P; British Society for Antimicrobial Chemotherapy Working Party on Neu-
rosurgical Infections. Spine update: prevention of postoperative infection in 
patients undergoing spinal surgery. Spine. 2004;29:938-45.
This study was a review of prophylactic antibiotic treatment for the 
prevention of wound infection. A positive effect was found in all six random-
ized, controlled studies cited. On the basis of this review, the authors recom-
mended cephalosporins for patients undergoing routine spinal surgery and 
recommended a combination of glycopeptide and gentamicin for those who 
are known carriers of methicillin-resistant staphyloccoeus sureus and those 
who are at risk for infection.
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Brown MD, Brookfield KF. A randomized study of closed wound suction 
drainage for extensive lumbar spine surgery. Spine. 2004;29:1066-8.
This was a prospective, randomized study of the risks and benefits as-
sociated with the use of closed suction drainage for patients undergoing ex-
tensive lumbar spine surgery. The authors reported no significant differences 
between patients with a drain and those without a drain with regard to infec-
tions, epidural hematomas, or new neurological deficits, and they concluded 
that drainage usage should be used at the discretion of the operating surgeon.
Buhrman M, Faltenhag S, Strom L, Andersson G. Controlled trial of Internet-
based treatment with telephone support for chronic back pain. Pain. 2004;
111:368-77.
This was a prospective, randomized trial in which a group of patients 
who were managed with an Internet-based pain-management program with-
telephone support (the treatment group) were compared with a group of 
patients who received no treatment (the control group). Although both 
groups demonstrated some improvement, the treatment group demon-
strated significant improvement with regard to control over pain and the 
ability to decrease pain.
Buttermann GR. Treatment of lumbar disc herniation: epidural steroid injec-
tion compared with discectomy. A prospective, randomized study. J Bone Joint 
Surg Am. 2004;86:670-9.
This was a very well-done study that compared the results of 
epidural steroid injection with those of surgical discectomy for the treat-
ment of lumbar disc herniation. The study strongly suggested that if a 
patient is not improving with tincture of time, the first step should be an 
epidural steroid injection and, if that does not alleviate the symptoms, then 
consideration should be given to surgical discectomy. This, of course, as-
sumes no contraindication to a steroid injection and no substantial neuro-
logic deficit.
Dey D, Simpson CW, Collins SI, Hodgson G, Dowrick CF, Simison AJ, Rose 
MJ. Implementation of RCGP guidelines for acute low back pain: a cluster 
randomised controlled trial. Br J Gen Pract. 2004;54:33-7.
This was an investigation of the impact of outreach visits to promote 
clinical guidelines for the treatment of low-back pain among primary-care 
teams in Northwest England. The adoption of clinical guidelines was not sig-
nificantly enhanced by systematic outreach intervention as a result of primary 
care physician referral to more expensive modalities such as specialist inter-
vention and pain clinic management in patients with persistent complaints of 
low-back pain. 
Fritzell P, Hagg O, Johnsson D, Nordwall A; Swedish Lumbar Spine Study 
Group. Cost-effectiveness of lumbar fusion in nonsurgical treatment for 
chronic low back pain in the Swedish Lumbar Spine Study: a multicenter, 
randomized, controlled trial from the Swedish Lumbar Spine Study Group. 
Spine. 2004;29:421-34, Z3.
Surgical fusion resulted in higher societal total costs and higher costs 
per patient for the health-care center than nonsurgical intervention did. How-
ever, treatment outcomes were significantly better in the surgical fusion 
group.
Gross AR, Hoving JL, Haines TA, Goldsmith CH, Kay T, Aker P, Bronfort G; 
Cervical Overview Group. A Cochrane review of manipulation and mobiliza-
tion for mechanical neck disorders. Spine. 2004;29:1541-8.
This was a systematic review of thirty-three randomized, controlled 
studies comparing various forms of manipulation and mobilization for the 
treatment of neck pain disorders. The authors found no evidence to support 
the use of manipulation or mobilization alone but reported that these modali-
ties appeared to be effective when combined with an active exercise program. 
The conclusions of the study were very limited because of inconsistent diag-
noses and the lack of control with regard to how mobilization and manipula-
tion were performed.
Gross DP, Battie MC, Cassidy JD. The prognostic value of functional capacity 
evaluation in patients with chronic low back pain: part I: timely return to 
work. Spine. 2004;29:914-9.
This historical cohort study evaluated the validity of a functional 
capacity work systems evaluation in predicting return to work among 150 
patients with low-back injury who were managed at a major Canadian reha-
bilitation center. The results of the functional capacity evaluation were only 
weakly associated with time to benefit suspension and return to work and ex-
plained only approximately 10% of the variations in outcome when associated 
variables were considered.
He D, Veiersted KB, Hostmark AT, Medbo JI. Effect of acupuncture treatment 
on chronic neck and shoulder pain in sedentary female workers: a 6-month 
and 3-year follow-up study. Pain. 2004;109:299-307.
This was a well-done randomized, controlled study in which acupunc-
ture was compared with sham acupuncture for the treatment of chronic, non-
disabling headache, neck pain, and shoulder pain in twenty-four office 
workers. The results at six months and three years demonstrated better pain 
relief, reduced headaches, and diminished muscle spasms in association with 
acupuncture.
Hurley DA, McDonough SM, Dempster M, Moore AP, Baxter GD. A ran-
domized clinical trial of manipulative therapy and interferential therapy for 
acute low back pain. Spine. 2004;29:2207-16.
This was a prospective, randomized trial that compared the use of ma-
nipulative therapy, interferential therapy, and a combination of both for the 
treatment of acute low-back pain. All patients were given a book of treatment 
information. The authors concluded that there was no difference between the 
effects of a combined program of manipulative therapy and interferential 
therapy and either manipulative therapy or interferential therapy alone.
Karjalainen K, Malmivaara A, Mutanen P, Roine R, Hurri H, Pohjolainen T. 
Mini-intervention for subacute low back pain: two-year follow-up and modi-
fiers of effectiveness. Spine. 2004;29:1069-76.
This was a prospective, randomized trial in which two types of mini-
intervention were compared with standard-of-care treatment for patients 
with subacute disabling low-back pain. Although the implementation of the 
mini-interventions (examinations, educational sessions, and careful explana-
tions of the typical course of low-back pain, with or without a worksite visit) 
did not have a significant effect on the intensity of the pain or perceived dis-
ability, the interventions did reduce daily symptoms, costs related to the low-
back pain, and absenteeism from work due to pain.
Khot A, Bowditch M, Powell J, Sharp D. The use of intradiscal steroid therapy 
for lumbar spinal discogenic pain: a randomized controlled trial. Spine. 
2004;29:833-7.
This was a prospective study in which intradiscal steroid injection 
was compared with intradiscal placebo injection for the treatment of chronic 
back pain of discogenic origin. The outcomes in the two groups were identi-
cal. Intradiscal steroid injection did not improve the clinical outcome in pa-
tients with discogenic back pain and, therefore, appears not to be an advisable 
procedure.
Liddle SD, Baxter GD, Gracey JH. Exercise and chronic low back pain: what 
works? Pain. 2004;107:176-90. Erratum in: Pain. 2004;109:200-1.
This was a systematic review of randomized, controlled studies evalu-
ating the effectiveness of the type and quality of exercise for patients with 
chronic low-back pain. Overall, patients with chronic low-back pain were 
positively influenced by a well-supervised exercise program, with the results 
being maintained in the majority of trials.
Ostelo RW, Goossens ME, de Vet HC, van den Brandt PA. Economical evalu-
ation of a behavioral-graded activity program compared to physical therapy 
for patients following lumbar disc surgery. Spine. 2004;29:615-22.
No significant improvement in outcome measures was noted when 
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patients who had received behavioral-graded activity treatment were com-
pared with those who had received normal postoperative physiotherapy. The 
authors concluded that such behavioral treatment programs are unnecessary 
following standard lumbar disc surgery because of cost issues.
Turner JA, Loeser JD, Deyo RA, Sanders SB. Spinal cord stimulation for pa-
tients with failed back surgery syndrome or complex regional pain syndrome: 
a systematic review of effectiveness and complications. Pain. 2004;108:137-47.
This study was a review of the existing literature regarding the effec-
tiveness of spinal cord stimulation for relieving pain and improving function 
in patients with failed back surgery syndrome and complex regional pain syn-
drome. The data were mixed with regard to whether spinal cord stimulation is 
helpful and effective for this class of patients, and such treatment was associ-
ated with complications and adverse occurrences. This article suggests that 
spinal cord stimulation is not the answer for this group of patients.
Yelland MJ, Mar C, Pirozzo S, Schoene ML, Vercoe P. Prolotherapy injections 
for chronic low-back pain. Cochrane Database Syst Rev. 2004;2:CD004059.
Prolotherapy is the injection of sclerosing agents, most commonly hy-
pertonic glucose, with the aim of reducing joint instability by strengthening 
damaged ligaments. This report presented the conflicting results from four 
randomized, controlled studies on the treatment of low-back pain, two of 
which showed no positive effect and two of which showed that additional co-
interventions had a positive effect. These results were further complicated by 
the heterogeneity among studies and by the presence of nonstandardized co-
interventions.
